BEUDAMED
    FDA Adverse Event Death Summary report: N

    EUFLEXXA

    MDR report key: 6964334 · Received October 20, 2017

    Report

    Report Number
    MW5072843
    Event Type
    Death
    Date Received
    October 20, 2017
    Date of Event
    July 22, 2017
    Report Date
    October 17, 2017
    Manufacturer
    FERRING PHARMACEUTICALS INC.
    Product Code
    MOZ
    UDI-DI
    55566410001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    PHARMACIST

    Narratives

    Description of Event or Problem · 1

    PATIENT DECEASED AS OF (B)(6) 2017. NO FURTHER INFORMATION. DOSE OR AMOUNT: 20 MG. FREQUENCY: Q3W. ROUTE: IA. DATES OF USE: (B)(6) 2017. DIAGNOSIS OR REASON FOR USE: UNILATERAL PRIMARY OSTEOPOROSIS. IS THE PRODUCT COMPOUNDED?: NO. IS THE PRODUCT OVER-THE-COUNTER?: NO.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    743945 EUFLEXXA ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC. M15199A 55566410001

    Patients

    Seq Age Sex Outcome Treatment
    1 90 YR Death